Inhibitors of the pulmonary angiotensin I-converting enzyme.
D000596:Amino Acids / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D008168:Lung / Q000201:enzymology*; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D011480:Protease Inhibitors; D011759:Pyrrolidines / Q000494:pharmacology; D011761:Pyrrolidonecarboxylic Acid / Q000494:pharmacology; D011817:Rabbits; D012911:Snakes; D013329:Structure-Activity Relationship; D013844:Thiazoles / Q000494:pharmacology; D013972:Thyrotropin / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology; D014688:Venoms / Q000494:pharmacology
D000596:Amino Acids; D000806:Angiotensin-Converting Enzyme Inhibitors; D003509:Cyclohexanecarboxylic Acids; D003517:Cyclopentanes; D008744:Methylamines; D010455:Peptides; D011480:Protease Inhibitors; D011759:Pyrrolidines; D013844:Thiazoles; D014688:Venoms; D014443:Tyrosine; D013972:Thyrotropin; D001920:Bradykinin; D011761:Pyrrolidonecarboxylic Acid